ETFsNASDAQ-100 Equal Weighted Net Notional Return Index
Invesco

Invesco NASDAQ-100 Equal Weight UCITS ETF Acc

EWQA XETRAIrelandNot PEA-eligible
Last close · EUR
6.85EUR
-3.25% · -€0.23
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
EWQABase
Fund charges
0.20%PRIIPs ongoing costs
Fund size
€105.1Mall share classes
Return 1Y
+14.2%
Sharpe 3Y
0.78
Volatility 1Y
14.5%annualised
Holdings
101Fund holdings

Performance

Compare
  • EWQA+14.2%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
EWQA-7.1%-3.9%+6.7%+15.1%+14.2%+47.6%-
MSCI World-2.8%-0.6%+7.8%+14.0%+14.1%+65.6%+64.8%
Gap to MSCI World-4.2%-3.3%-1.1%+1.1%+0.1%-18.0%-

Risk and return

Sharpe ratio · 3Y
0.78
Below MSCI World · 1.24
Return p.a.
+15.2%
Volatility
16.4%
Max loss
-25.9%Apr 2025

Sharpe vs indices

MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
EWQA
0.78
CAC 40
0.37
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
12.8%
Holdings
101
As of
Fund holdings
  1. 1MODERNA INC USD0.0001US60770K10791.50%
  2. 2INTUITIVE SURGICAL INC USD0.001US46120E60231.32%
  3. 3IDEXX LABORATORIES INC USD0.1US45168D10461.29%
  4. 4MARRIOTT INTERNATIONAL -CL A USD0.01US57190320221.28%
  5. 5WALMART INC USD0.1US93114210391.27%
  6. 6GE HEALTHCARE TECHNOLOG-W/I USD NPVUS36266G10761.24%
  7. 7TEXAS INSTRUMENTS INC USD1US88250810401.24%
  8. 8GILEAD SCIENCES INC USD0.001US37555810361.23%
  9. 9NXP SEMICONDUCTORS NV NPVNL00095387841.22%
  10. 10REGENERON PHARMACEUTICALS USD0.001US75886F10751.20%

Countries

Not published · Country classification unavailable

Market cap

Weight vs holdings

12.8%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-101

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.